MAPT and Alzheimer disease: This is in agreement with previous observations by us and others [25, 30–32, 35, 46], and favors the idea that these three tracers bind with significantly stronger affinity and selectivity to tau aggregates in AD but they all seem to have low affinity for tau aggregates in non-AD tauopathies.